ReP USP - Resultado da busca

Artigo de periodico
Chronic inflammatory diseases, subclinical atherosclerosis, and cardiovascular diseases: design, objectives, and baseline characteristics of a prospective case-cohort study ‒ ELSA-Brasil (2022)
Benseñor, Isabela Judith Martins ; Goulart, Alessandra Carvalho ; Pereira, Alexandre C.; Brunoni, Andre Russowsky ; Alencar, Airlane Pereira ; Santos, Raul D. ; Bittencourt, Márcio Sommer ; Telles, Rosa W.; Machado, Luciana Andrade Carneiro; Barreto, Sandhi Maria ; Pititto, Bianca de Almeida ; Janovsky, Carolina Porto Silva ; Sgarbi, José Augusto ; Tebar, William Rodrigues; Meneghini, Vandrize ; Barbosa Junior, Fernando ; Ribeiro, Ana Cristina de Medeiros; Pasoto, Sandra Gofinet ; Pereira, Rosa Maria Rodrigues ; Bonfa, Eloisa Silva Dutra de Oliveira ; Sipahi, Aytan Miranda ; Santos, Itamar de Souza ; Lotufo, Paulo Andrade
Source: Clinics. Unidades: FM, HU, IME, FCFRP
Subjects: DOENÇA CRÔNICA, DOENÇAS CARDIOVASCULARES, ANÁLISE DE VARIÂNCIA, REGRESSÃO LOGÍSTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BENSEÑOR, Isabela Judith Martins et al. Chronic inflammatory diseases, subclinical atherosclerosis, and cardiovascular diseases: design, objectives, and baseline characteristics of a prospective case-cohort study ‒ ELSA-Brasil. Clinics, v. 77, n. artigo 100013, p. 1-7, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.clinsp.2022.100013. Acesso em: 08 fev. 2023.
APA
Benseñor, I. J. M., Goulart, A. C., Pereira, A. C., Brunoni, A. R., Alencar, A. P., Santos, R. D., et al. (2022). Chronic inflammatory diseases, subclinical atherosclerosis, and cardiovascular diseases: design, objectives, and baseline characteristics of a prospective case-cohort study ‒ ELSA-Brasil. Clinics, 77( artigo 100013), 1-7. doi:10.1016/j.clinsp.2022.100013
NLM
Benseñor IJM, Goulart AC, Pereira AC, Brunoni AR, Alencar AP, Santos RD, Bittencourt MS, Telles RW, Machado LAC, Barreto SM, Pititto B de A, Janovsky CPS, Sgarbi JA, Tebar WR, Meneghini V, Barbosa Junior F, Ribeiro AC de M, Pasoto SG, Pereira RMR, Bonfa ESD de O, Sipahi AM, Santos I de S, Lotufo PA. Chronic inflammatory diseases, subclinical atherosclerosis, and cardiovascular diseases: design, objectives, and baseline characteristics of a prospective case-cohort study ‒ ELSA-Brasil [Internet]. Clinics. 2022 ; 77( artigo 100013): 1-7.[citado 2023 fev. 08 ] Available from: https://doi.org/10.1016/j.clinsp.2022.100013
Vancouver
Benseñor IJM, Goulart AC, Pereira AC, Brunoni AR, Alencar AP, Santos RD, Bittencourt MS, Telles RW, Machado LAC, Barreto SM, Pititto B de A, Janovsky CPS, Sgarbi JA, Tebar WR, Meneghini V, Barbosa Junior F, Ribeiro AC de M, Pasoto SG, Pereira RMR, Bonfa ESD de O, Sipahi AM, Santos I de S, Lotufo PA. Chronic inflammatory diseases, subclinical atherosclerosis, and cardiovascular diseases: design, objectives, and baseline characteristics of a prospective case-cohort study ‒ ELSA-Brasil [Internet]. Clinics. 2022 ; 77( artigo 100013): 1-7.[citado 2023 fev. 08 ] Available from: https://doi.org/10.1016/j.clinsp.2022.100013
Artigo de periodico
Association of dietary patterns and components with atherosclerosis risk biomarkers in familial hypercholesterolemia (2022)
Antoniazi, Luiza; Arroyo-olivares, Raquel; Mata, Pedro; Santos, Raul D.
Source: Current opinion in lipidology. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, DOENÇAS CARDIOVASCULARES, ARTERIOSCLEROSE, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANTONIAZI, Luiza et al. Association of dietary patterns and components with atherosclerosis risk biomarkers in familial hypercholesterolemia. Current opinion in lipidology, v. 33, n. 2, p. 89-94, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/45903. Acesso em: 08 fev. 2023.
APA
Antoniazi, L., Arroyo-olivares, R., Mata, P., & Santos, R. D. (2022). Association of dietary patterns and components with atherosclerosis risk biomarkers in familial hypercholesterolemia. Current opinion in lipidology, 33( 2), 89-94. doi:10.1097/MOL.0000000000000813
NLM
Antoniazi L, Arroyo-olivares R, Mata P, Santos RD. Association of dietary patterns and components with atherosclerosis risk biomarkers in familial hypercholesterolemia [Internet]. Current opinion in lipidology. 2022 ; 33( 2): 89-94.[citado 2023 fev. 08 ] Available from: https://observatorio.fm.usp.br/handle/OPI/45903
Vancouver
Antoniazi L, Arroyo-olivares R, Mata P, Santos RD. Association of dietary patterns and components with atherosclerosis risk biomarkers in familial hypercholesterolemia [Internet]. Current opinion in lipidology. 2022 ; 33( 2): 89-94.[citado 2023 fev. 08 ] Available from: https://observatorio.fm.usp.br/handle/OPI/45903
Artigo de periodico
COVID-19 and Thromboinflammation: Is There a Role for Statins? (2021)
Ferrari, Filipe; Martins, Vitor M.; Teixeira, Marcelo; Santos, Raul D. ; Stein, Ricardo
Source: Clinics.
Subjects: COVID-19, TROMBOSE, INFLAMAÇÃO, ARTERIOSCLEROSE, ESTATINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERRARI, Filipe et al. COVID-19 and Thromboinflammation: Is There a Role for Statins?. Clinics, v. 76, 2021Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/42149. Acesso em: 08 fev. 2023.
APA
Ferrari, F., Martins, V. M., Teixeira, M., Santos, R. D., & Stein, R. (2021). COVID-19 and Thromboinflammation: Is There a Role for Statins? Clinics, 76. doi:10.6061/clinics/2021/e2518
NLM
Ferrari F, Martins VM, Teixeira M, Santos RD, Stein R. COVID-19 and Thromboinflammation: Is There a Role for Statins? [Internet]. Clinics. 2021 ; 76[citado 2023 fev. 08 ] Available from: https://observatorio.fm.usp.br/handle/OPI/42149
Vancouver
Ferrari F, Martins VM, Teixeira M, Santos RD, Stein R. COVID-19 and Thromboinflammation: Is There a Role for Statins? [Internet]. Clinics. 2021 ; 76[citado 2023 fev. 08 ] Available from: https://observatorio.fm.usp.br/handle/OPI/42149
Artigo de periodico
Statin Eligibility in Primary Prevention: From a Risk-Based Strategy to a Personalized Approach Based on the Predicted Benefit (2018)
Cesena, Fernando H. Y.; Santos, Raul D.
Source: American journal of cardiology. Unidade: HU
Subjects: DOENÇAS CARDIOVASCULARES, FATORES DE RISCO, FÁRMACOS, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CESENA, Fernando H. Y. e SANTOS, Raul D. Statin Eligibility in Primary Prevention: From a Risk-Based Strategy to a Personalized Approach Based on the Predicted Benefit. American journal of cardiology, v. 121, n. 11, p. 1315-1320, 2018Tradução . . Disponível em: http://dx.doi.org/10.1016/j.amjcard.2018.02.011. Acesso em: 08 fev. 2023.
APA
Cesena, F. H. Y., & Santos, R. D. (2018). Statin Eligibility in Primary Prevention: From a Risk-Based Strategy to a Personalized Approach Based on the Predicted Benefit. American journal of cardiology, 121( 11), 1315-1320. doi:10.1016/j.amjcard.2018.02.011
NLM
Cesena FHY, Santos RD. Statin Eligibility in Primary Prevention: From a Risk-Based Strategy to a Personalized Approach Based on the Predicted Benefit [Internet]. American journal of cardiology. 2018 ; 121( 11): 1315-1320.[citado 2023 fev. 08 ] Available from: http://dx.doi.org/10.1016/j.amjcard.2018.02.011
Vancouver
Cesena FHY, Santos RD. Statin Eligibility in Primary Prevention: From a Risk-Based Strategy to a Personalized Approach Based on the Predicted Benefit [Internet]. American journal of cardiology. 2018 ; 121( 11): 1315-1320.[citado 2023 fev. 08 ] Available from: http://dx.doi.org/10.1016/j.amjcard.2018.02.011
Artigo de periodico
Estimated costs of hospitalization due to coronary artery disease attributable to familial hypercholesterolemia in the Brazilian public health system (2018)
Bahia, Luciana R.; Santos, Raul D.; Araujo, Denizar V.; Rosa, Roger S.; Bahia, Luciana R.
Source: Archives of endocrinology metabolism. Unidade: FM
Subjects: PACIENTES INTERNADOS, CUSTOS DOS CUIDADOS DE SAÚDE, DOENÇAS CARDIOVASCULARES, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BAHIA, Luciana R. et al. Estimated costs of hospitalization due to coronary artery disease attributable to familial hypercholesterolemia in the Brazilian public health system. Archives of endocrinology metabolism, v. 62, n. 3, p. 303-308, 2018Tradução . . Disponível em: http://dx.doi.org/10.20945/2359-3997000000030. Acesso em: 08 fev. 2023.
APA
Bahia, L. R., Santos, R. D., Araujo, D. V., Rosa, R. S., & Bahia, L. R. (2018). Estimated costs of hospitalization due to coronary artery disease attributable to familial hypercholesterolemia in the Brazilian public health system. Archives of endocrinology metabolism, 62( 3), 303-308. doi:10.20945/2359-3997000000030
NLM
Bahia LR, Santos RD, Araujo DV, Rosa RS, Bahia LR. Estimated costs of hospitalization due to coronary artery disease attributable to familial hypercholesterolemia in the Brazilian public health system [Internet]. Archives of endocrinology metabolism. 2018 ; 62( 3): 303-308.[citado 2023 fev. 08 ] Available from: http://dx.doi.org/10.20945/2359-3997000000030
Vancouver
Bahia LR, Santos RD, Araujo DV, Rosa RS, Bahia LR. Estimated costs of hospitalization due to coronary artery disease attributable to familial hypercholesterolemia in the Brazilian public health system [Internet]. Archives of endocrinology metabolism. 2018 ; 62( 3): 303-308.[citado 2023 fev. 08 ] Available from: http://dx.doi.org/10.20945/2359-3997000000030
Artigo de periodico
Clinical Genetic Testing for Familial Hypercholesterolemia (2018)
Sturm, Amy C.; Santos, Raul D.
Source: Journal of the american college of cardiology. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, DOENÇAS CARDIOVASCULARES, COLESTEROL, CUSTOS DOS CUIDADOS DE SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STURM, Amy C. e SANTOS, Raul D. Clinical Genetic Testing for Familial Hypercholesterolemia. Journal of the american college of cardiology, v. 72, n. 6, p. 662-680, 2018Tradução . . Disponível em: http://dx.doi.org/10.1016/j.jacc.2018.05.044. Acesso em: 08 fev. 2023.
APA
Sturm, A. C., & Santos, R. D. (2018). Clinical Genetic Testing for Familial Hypercholesterolemia. Journal of the american college of cardiology, 72( 6), 662-680. doi:10.1016/j.jacc.2018.05.044
NLM
Sturm AC, Santos RD. Clinical Genetic Testing for Familial Hypercholesterolemia [Internet]. Journal of the american college of cardiology. 2018 ; 72( 6): 662-680.[citado 2023 fev. 08 ] Available from: http://dx.doi.org/10.1016/j.jacc.2018.05.044
Vancouver
Sturm AC, Santos RD. Clinical Genetic Testing for Familial Hypercholesterolemia [Internet]. Journal of the american college of cardiology. 2018 ; 72( 6): 662-680.[citado 2023 fev. 08 ] Available from: http://dx.doi.org/10.1016/j.jacc.2018.05.044
Artigo de periodico
Predictors of Family Enrollment in a Genetic Cascade Screening Program for Familial Hypercholesterolemia (2018)
Silva, Pamela Rodrigues de Souza; Krieger, Jose E.; Santos, Raul D.; Jannes, Cinthia Elim; Oliveira, Theo G. M.; Gomez, Luz Marina Gome; Pereira, Alexandre Costa
Source: Arquivos Brasileiros de Cardiologia. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, GENÉTICA, COLESTEROL, DISLIPIDEMIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Pamela Rodrigues de Souza et al. Predictors of Family Enrollment in a Genetic Cascade Screening Program for Familial Hypercholesterolemia. Arquivos Brasileiros de Cardiologia, v. 111, n. 4, p. 578-583, 2018Tradução . . Disponível em: http://dx.doi.org/10.5935/abc.20180156. Acesso em: 08 fev. 2023.
APA
Silva, P. R. de S., Krieger, J. E., Santos, R. D., Jannes, C. E., Oliveira, T. G. M., Gomez, L. M. G., & Pereira, A. C. (2018). Predictors of Family Enrollment in a Genetic Cascade Screening Program for Familial Hypercholesterolemia. Arquivos Brasileiros de Cardiologia, 111( 4), 578-583. doi:10.5935/abc.20180156
NLM
Silva PR de S, Krieger JE, Santos RD, Jannes CE, Oliveira TGM, Gomez LMG, Pereira AC. Predictors of Family Enrollment in a Genetic Cascade Screening Program for Familial Hypercholesterolemia [Internet]. Arquivos Brasileiros de Cardiologia. 2018 ; 111( 4): 578-583.[citado 2023 fev. 08 ] Available from: http://dx.doi.org/10.5935/abc.20180156
Vancouver
Silva PR de S, Krieger JE, Santos RD, Jannes CE, Oliveira TGM, Gomez LMG, Pereira AC. Predictors of Family Enrollment in a Genetic Cascade Screening Program for Familial Hypercholesterolemia [Internet]. Arquivos Brasileiros de Cardiologia. 2018 ; 111( 4): 578-583.[citado 2023 fev. 08 ] Available from: http://dx.doi.org/10.5935/abc.20180156
Artigo de periodico
Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS) (2018)
Danchin, Nicolas; Santos, Raul D.
Source: European journal of preventive cardiology. Unidade: FM
Subjects: ESTATINAS, DOENÇAS CARDIOVASCULARES, COLESTEROL, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DANCHIN, Nicolas e SANTOS, Raul D. Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS). European journal of preventive cardiology, v. 25, n. 10, p. 1087-1094, 2018Tradução . . Disponível em: http://dx.doi.org/10.1177/2047487318777079. Acesso em: 08 fev. 2023.
APA
Danchin, N., & Santos, R. D. (2018). Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS). European journal of preventive cardiology, 25( 10), 1087-1094. doi:10.1177/2047487318777079
NLM
Danchin N, Santos RD. Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS) [Internet]. European journal of preventive cardiology. 2018 ; 25( 10): 1087-1094.[citado 2023 fev. 08 ] Available from: http://dx.doi.org/10.1177/2047487318777079
Vancouver
Danchin N, Santos RD. Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS) [Internet]. European journal of preventive cardiology. 2018 ; 25( 10): 1087-1094.[citado 2023 fev. 08 ] Available from: http://dx.doi.org/10.1177/2047487318777079
Artigo de periodico
Prevalence, management, and outcomes of familial hypercholesterolemia in patients with acute coronary syndromes in the Arabian Gulf (2018)
Al-rasadi, Khalid; Santos, Raul D.
Source: Journal of clinical lipidology. Unidade: FM
Subjects: ARÁBIA, HIPERCOLESTEROLEMIA, DIABETES MELLITUS, PROGNÓSTICO, SÍNDROME CORONARIANA AGUDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AL-RASADI, Khalid e SANTOS, Raul D. Prevalence, management, and outcomes of familial hypercholesterolemia in patients with acute coronary syndromes in the Arabian Gulf. Journal of clinical lipidology, v. 12, n. 3, p. 685-692, 2018Tradução . . Disponível em: http://dx.doi.org/10.1016/j.jacl.2018.02.003. Acesso em: 08 fev. 2023.
APA
Al-rasadi, K., & Santos, R. D. (2018). Prevalence, management, and outcomes of familial hypercholesterolemia in patients with acute coronary syndromes in the Arabian Gulf. Journal of clinical lipidology, 12( 3), 685-692. doi:10.1016/j.jacl.2018.02.003
NLM
Al-rasadi K, Santos RD. Prevalence, management, and outcomes of familial hypercholesterolemia in patients with acute coronary syndromes in the Arabian Gulf [Internet]. Journal of clinical lipidology. 2018 ; 12( 3): 685-692.[citado 2023 fev. 08 ] Available from: http://dx.doi.org/10.1016/j.jacl.2018.02.003
Vancouver
Al-rasadi K, Santos RD. Prevalence, management, and outcomes of familial hypercholesterolemia in patients with acute coronary syndromes in the Arabian Gulf [Internet]. Journal of clinical lipidology. 2018 ; 12( 3): 685-692.[citado 2023 fev. 08 ] Available from: http://dx.doi.org/10.1016/j.jacl.2018.02.003
Artigo de periodico
PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia (2017)
Ito, Matthew K.; Santos, Raul D.
Source: The Journal of Clinical Pharmacology. Unidade: FM
Subjects: LIPÍDEOS, ANTICORPOS MONOCLONAIS, HIPERCOLESTEROLEMIA, DOENÇAS GENÉTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ITO, Matthew K. e SANTOS, Raul D. PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia. The Journal of Clinical Pharmacology, v. 57, n. 1, p. 7-32, 2017Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/jcph.766/epdf. Acesso em: 08 fev. 2023.
APA
Ito, M. K., & Santos, R. D. (2017). PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia. The Journal of Clinical Pharmacology, 57( 1), 7-32. doi:10.1002/jcph.766
NLM
Ito MK, Santos RD. PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 1): 7-32.[citado 2023 fev. 08 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/jcph.766/epdf
Vancouver
Ito MK, Santos RD. PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 1): 7-32.[citado 2023 fev. 08 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/jcph.766/epdf
Artigo de periodico
Prevalência de Diagnóstico Médico de Colesterol Alto Autorreferido na População Brasileira: Análise da Pesquisa Nacional de Saúde, 2013 (2017)
Lotufo, Paulo A.; Santos, Raul D.; Sposito, Andrei C.; Bertolami, Marcelo; Rocha-Faria Neto, Jose; Izar, M. Cristina; Szwarcwald, Celia; Prado, Rogério R.; Stoppa, Sheila R.; Malta, Deborah C.; Bensenor, Isabela M.
Source: Arquivos Brasileiros de Cardiologia. Unidade: FM
Subjects: COLESTEROL, DISLIPIDEMIAS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOTUFO, Paulo A. et al. Prevalência de Diagnóstico Médico de Colesterol Alto Autorreferido na População Brasileira: Análise da Pesquisa Nacional de Saúde, 2013. Arquivos Brasileiros de Cardiologia, v. 108, n. 5, p. 411-416, 2017Tradução . . Disponível em: http://www.scielo.br/pdf/abc/v108n5/pt_0066-782X-abc-108-05-0411.pdf. Acesso em: 08 fev. 2023.
APA
Lotufo, P. A., Santos, R. D., Sposito, A. C., Bertolami, M., Rocha-Faria Neto, J., Izar, M. C., et al. (2017). Prevalência de Diagnóstico Médico de Colesterol Alto Autorreferido na População Brasileira: Análise da Pesquisa Nacional de Saúde, 2013. Arquivos Brasileiros de Cardiologia, 108( 5), 411-416. doi:10.5935/abc.20170055
NLM
Lotufo PA, Santos RD, Sposito AC, Bertolami M, Rocha-Faria Neto J, Izar MC, Szwarcwald C, Prado RR, Stoppa SR, Malta DC, Bensenor IM. Prevalência de Diagnóstico Médico de Colesterol Alto Autorreferido na População Brasileira: Análise da Pesquisa Nacional de Saúde, 2013 [Internet]. Arquivos Brasileiros de Cardiologia. 2017 ; 108( 5): 411-416.[citado 2023 fev. 08 ] Available from: http://www.scielo.br/pdf/abc/v108n5/pt_0066-782X-abc-108-05-0411.pdf
Vancouver
Lotufo PA, Santos RD, Sposito AC, Bertolami M, Rocha-Faria Neto J, Izar MC, Szwarcwald C, Prado RR, Stoppa SR, Malta DC, Bensenor IM. Prevalência de Diagnóstico Médico de Colesterol Alto Autorreferido na População Brasileira: Análise da Pesquisa Nacional de Saúde, 2013 [Internet]. Arquivos Brasileiros de Cardiologia. 2017 ; 108( 5): 411-416.[citado 2023 fev. 08 ] Available from: http://www.scielo.br/pdf/abc/v108n5/pt_0066-782X-abc-108-05-0411.pdf
Artigo de periodico
Clinical and molecular aspects of familial hypercholesterolemia in Ibero-American countries (2017)
Santos, Raul D.; Bourbon, Mafalda; Alonso, Rodrigo; Cuevas, Ada; Vasques-Cardenas, Norma Alexandra; Pereira, Alexandre C.; Merchan, Alonso; Alves, Ana Catarina; Medeiros, Ana Margarida; Jannes, Cinthia E.; Krieger, Jose E.; Schreier, Laura; Isla, Leopoldo Perez de; Magana-Torres, Maria Teresa; Stoll, Mario; Mata, Nelva; Dell Oca, Nicolas; Corral, Pablo; Asenjo, Sylvia; Banares, Virginia G.; Reyes, Ximena; Mata, Pedro
Source: Journal of clinical lipidology. Unidade: FM
Subjects: RASTREAMENTO, COLESTEROL, HIPERCOLESTEROLEMIA, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Raul D. et al. Clinical and molecular aspects of familial hypercholesterolemia in Ibero-American countries. Journal of clinical lipidology, n. 1, p. 160-166, 2017Tradução . . Disponível em: http://dx.doi.org/10.1016/j.jacl.2016.11.004. Acesso em: 08 fev. 2023.
APA
Santos, R. D., Bourbon, M., Alonso, R., Cuevas, A., Vasques-Cardenas, N. A., Pereira, A. C., et al. (2017). Clinical and molecular aspects of familial hypercholesterolemia in Ibero-American countries. Journal of clinical lipidology, ( 1), 160-166. doi:10.1016/j.jacl.2016.11.004
NLM
Santos RD, Bourbon M, Alonso R, Cuevas A, Vasques-Cardenas NA, Pereira AC, Merchan A, Alves AC, Medeiros AM, Jannes CE, Krieger JE, Schreier L, Isla LP de, Magana-Torres MT, Stoll M, Mata N, Dell Oca N, Corral P, Asenjo S, Banares VG, Reyes X, Mata P. Clinical and molecular aspects of familial hypercholesterolemia in Ibero-American countries [Internet]. Journal of clinical lipidology. 2017 ;( 1): 160-166.[citado 2023 fev. 08 ] Available from: http://dx.doi.org/10.1016/j.jacl.2016.11.004
Vancouver
Santos RD, Bourbon M, Alonso R, Cuevas A, Vasques-Cardenas NA, Pereira AC, Merchan A, Alves AC, Medeiros AM, Jannes CE, Krieger JE, Schreier L, Isla LP de, Magana-Torres MT, Stoll M, Mata N, Dell Oca N, Corral P, Asenjo S, Banares VG, Reyes X, Mata P. Clinical and molecular aspects of familial hypercholesterolemia in Ibero-American countries [Internet]. Journal of clinical lipidology. 2017 ;( 1): 160-166.[citado 2023 fev. 08 ] Available from: http://dx.doi.org/10.1016/j.jacl.2016.11.004
Artigo de periodico
Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM) (2017)
Bertoluci, Marcello Casaccia; Moreira, Rodrigo Oliveira; Faludi, André; Izar, Maria Cristina; Schaan, Beatriz D.; Valerio, Cynthia Melissa; Bertolami, Marcelo Chiara; Chacra, Ana Paula; Malachias, Marcus Vinicius Bolivar; Vencio, Sérgio; Saraiva, José Francisco Kerr; Betti, Roberto; Turatti, Luiz; Fonseca, Francisco Antonio Helfenstein; Bianco, Henrique Tria; Sulzbach, Marta; Bertolami, Adriana; Salles, João Eduardo Nunes; Hohl, Alexandre; Trujilho, Fábio; Lima, Eduardo Gomes; Miname, Marcio Hiroshi; Zanella, Maria Teresa; Lamounier, Rodrigo; Sá, João Roberto; Amodeo, Celso; Pires, Antonio Carlos; Santos, Raul D.
Source: Diabetology and Metabolic Syndrome. Unidade: FM
Subjects: DIABETES MELLITUS, GUIAS, DOENÇAS CARDIOVASCULARES, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERTOLUCI, Marcello Casaccia et al. Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM). Diabetology and Metabolic Syndrome, v. 9, n. 53, p. 36 , 2017Tradução . . Disponível em: https://doi.org/10.1186/s13098-017-0251-z. Acesso em: 08 fev. 2023.
APA
Bertoluci, M. C., Moreira, R. O., Faludi, A., Izar, M. C., Schaan, B. D., Valerio, C. M., et al. (2017). Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM). Diabetology and Metabolic Syndrome, 9( 53), 36 . doi:10.1186/s13098-017-0251-z
NLM
Bertoluci MC, Moreira RO, Faludi A, Izar MC, Schaan BD, Valerio CM, Bertolami MC, Chacra AP, Malachias MVB, Vencio S, Saraiva JFK, Betti R, Turatti L, Fonseca FAH, Bianco HT, Sulzbach M, Bertolami A, Salles JEN, Hohl A, Trujilho F, Lima EG, Miname MH, Zanella MT, Lamounier R, Sá JR, Amodeo C, Pires AC, Santos RD. Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM) [Internet]. Diabetology and Metabolic Syndrome. 2017 ; 9( 53): 36 .[citado 2023 fev. 08 ] Available from: https://doi.org/10.1186/s13098-017-0251-z
Vancouver
Bertoluci MC, Moreira RO, Faludi A, Izar MC, Schaan BD, Valerio CM, Bertolami MC, Chacra AP, Malachias MVB, Vencio S, Saraiva JFK, Betti R, Turatti L, Fonseca FAH, Bianco HT, Sulzbach M, Bertolami A, Salles JEN, Hohl A, Trujilho F, Lima EG, Miname MH, Zanella MT, Lamounier R, Sá JR, Amodeo C, Pires AC, Santos RD. Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM) [Internet]. Diabetology and Metabolic Syndrome. 2017 ; 9( 53): 36 .[citado 2023 fev. 08 ] Available from: https://doi.org/10.1186/s13098-017-0251-z
Artigo de periodico
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients (2017)
Ridker, Paul M.; Revkin, James; Amarenco, Pierre; Brunell, Robert; Curto, Madelyn; Civeira, Fernando; Flather, Marcus; Glynn, Robert J.; Gregoire, Jean; Jukema, J. Wouter; Karpov, Yuri; Kastelein, John J.P.; Koenig, Wolfgang; Lorenzatti, Alberto; Manga, Pravin; Masiukiewicz, Urszula; Miller, Michael; Mosterd, Arend; Murin, Jan; Nicolau, Jose C.; Nissen, Steven; Ponikowski, Piotr; Santos, Raul D.; Schwartz, Pamela F.; Soran, Handrean; White, Harvey; Wright, R. Scott; Vrablik, Michal; Yunis, Carla; Shear, Charles L.; Tardif, Jean-Claude
Source: The New England Journal of Medicine. Unidade: FM
Subjects: COLESTEROL, PLACEBO, ANTICORPOS MONOCLONAIS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIDKER, Paul M. et al. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. The New England Journal of Medicine, v. 376, n. 16, p. 1527-1539, 2017Tradução . . Disponível em: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1701488. Acesso em: 08 fev. 2023.
APA
Ridker, P. M., Revkin, J., Amarenco, P., Brunell, R., Curto, M., Civeira, F., et al. (2017). Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. The New England Journal of Medicine, 376( 16), 1527-1539. doi:10.1056/NEJMoa1701488
NLM
Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif J-C. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients [Internet]. The New England Journal of Medicine. 2017 ; 376( 16): 1527-1539.[citado 2023 fev. 08 ] Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1701488
Vancouver
Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif J-C. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients [Internet]. The New England Journal of Medicine. 2017 ; 376( 16): 1527-1539.[citado 2023 fev. 08 ] Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1701488
Artigo de periodico-carta/editorial
Subclinical carotid vascular disease and risk factors for atherosclerosis in type 1 and type 2 diabetes [Editorial] (2017)
Rocha, Viviane Z.; Santos, Raul D.
Source: Archives of Endocrinology and Metabolism. Unidade: FM
Subjects: ADULTOS, ARTERIOSCLEROSE, MULHERES, DIABETES MELLITUS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Viviane Z. e SANTOS, Raul D. Subclinical carotid vascular disease and risk factors for atherosclerosis in type 1 and type 2 diabetes [Editorial]. Archives of Endocrinology and Metabolism. São Paulo: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.scielo.br/pdf/aem/v61n2/0004-2730-aem-61-2-0105.pdf. Acesso em: 08 fev. 2023. , 2017
APA
Rocha, V. Z., & Santos, R. D. (2017). Subclinical carotid vascular disease and risk factors for atherosclerosis in type 1 and type 2 diabetes [Editorial]. Archives of Endocrinology and Metabolism. São Paulo: Faculdade de Medicina, Universidade de São Paulo. doi:10.1590/2359-3997000000264
NLM
Rocha VZ, Santos RD. Subclinical carotid vascular disease and risk factors for atherosclerosis in type 1 and type 2 diabetes [Editorial] [Internet]. Archives of Endocrinology and Metabolism. 2017 ; 61( 2): 105-107.[citado 2023 fev. 08 ] Available from: http://www.scielo.br/pdf/aem/v61n2/0004-2730-aem-61-2-0105.pdf
Vancouver
Rocha VZ, Santos RD. Subclinical carotid vascular disease and risk factors for atherosclerosis in type 1 and type 2 diabetes [Editorial] [Internet]. Archives of Endocrinology and Metabolism. 2017 ; 61( 2): 105-107.[citado 2023 fev. 08 ] Available from: http://www.scielo.br/pdf/aem/v61n2/0004-2730-aem-61-2-0105.pdf
Artigo de periodico
Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab (2017)
Ridker, Paul M.; Tardif, Jean-Claude; Amarenco, Pierre; Duggan, William; Glynn, Robert J.; Jukema, J. Wouter; Kastelein, John J.P.; Kim, Albert M.; Koenig, Wolfgang; Nissen, Steven; Revkin, James; Rose, Lynda M.; Santos, Raul D.; Schwartz, Pamela F.; Shear, Charles L.; Yunis, Carla
Source: The New England Journal of Medicine. Unidade: FM
Subjects: COLESTEROL, FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, ANTICORPOS MONOCLONAIS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIDKER, Paul M. et al. Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab. The New England Journal of Medicine, v. 376, n. 16, p. 1517-1526, 2017Tradução . . Disponível em: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1614062. Acesso em: 08 fev. 2023.
APA
Ridker, P. M., Tardif, J. -C., Amarenco, P., Duggan, W., Glynn, R. J., Jukema, J. W., et al. (2017). Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab. The New England Journal of Medicine, 376( 16), 1517-1526. doi:10.1056/NEJMoa1614062
NLM
Ridker PM, Tardif J-C, Amarenco P, Duggan W, Glynn RJ, Jukema JW, Kastelein JJP, Kim AM, Koenig W, Nissen S, Revkin J, Rose LM, Santos RD, Schwartz PF, Shear CL, Yunis C. Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab [Internet]. The New England Journal of Medicine. 2017 ; 376( 16): 1517-1526.[citado 2023 fev. 08 ] Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1614062
Vancouver
Ridker PM, Tardif J-C, Amarenco P, Duggan W, Glynn RJ, Jukema JW, Kastelein JJP, Kim AM, Koenig W, Nissen S, Revkin J, Rose LM, Santos RD, Schwartz PF, Shear CL, Yunis C. Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab [Internet]. The New England Journal of Medicine. 2017 ; 376( 16): 1517-1526.[citado 2023 fev. 08 ] Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1614062
Artigo de periodico
Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns? (2016)
Banerjee, Yajnavalka; Santos, Raul D.; Al-Rasadi, Khalid; Rizzo, Manfredi
Source: Atherosclerosis. Unidade: FM
Subjects: MUTAÇÃO GENÉTICA, LIPÍDEOS, ANTICORPOS MONOCLONAIS, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BANERJEE, Yajnavalka et al. Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns?. Atherosclerosis, v. 248, n. 1, p. 62-75, 2016Tradução . . Disponível em: http://dx.doi.org/10.1016/j.atherosclerosis.2016.02.018. Acesso em: 08 fev. 2023.
APA
Banerjee, Y., Santos, R. D., Al-Rasadi, K., & Rizzo, M. (2016). Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns? Atherosclerosis, 248( 1), 62-75. doi:10.1016/j.atherosclerosis.2016.02.018
NLM
Banerjee Y, Santos RD, Al-Rasadi K, Rizzo M. Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns? [Internet]. Atherosclerosis. 2016 ; 248( 1): 62-75.[citado 2023 fev. 08 ] Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2016.02.018
Vancouver
Banerjee Y, Santos RD, Al-Rasadi K, Rizzo M. Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns? [Internet]. Atherosclerosis. 2016 ; 248( 1): 62-75.[citado 2023 fev. 08 ] Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2016.02.018
Artigo de periodico
Predictors of cardiovascular events after one year of molecular screening for Familial hypercholesterolemia (2016)
Silva, Pãmela R. S.; Jannes, Cinthia E.; Marsiglia, Julia D. C.; Krieger, Jose E.; Santos, Raul D.; Pereira, Alexandre C.
Source: Atherosclerosis. Unidade: FM
Subjects: DOENÇAS CARDIOVASCULARES, SINAIS E SINTOMAS, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Pãmela R. S. et al. Predictors of cardiovascular events after one year of molecular screening for Familial hypercholesterolemia. Atherosclerosis, v. 248, n. 1, p. 144-150, 2016Tradução . . Disponível em: http://dx.doi.org/10.1016/j.atherosclerosis.2016.05.023. Acesso em: 08 fev. 2023.
APA
Silva, P. R. S., Jannes, C. E., Marsiglia, J. D. C., Krieger, J. E., Santos, R. D., & Pereira, A. C. (2016). Predictors of cardiovascular events after one year of molecular screening for Familial hypercholesterolemia. Atherosclerosis, 248( 1), 144-150. doi:10.1016/j.atherosclerosis.2016.05.023
NLM
Silva PRS, Jannes CE, Marsiglia JDC, Krieger JE, Santos RD, Pereira AC. Predictors of cardiovascular events after one year of molecular screening for Familial hypercholesterolemia [Internet]. Atherosclerosis. 2016 ; 248( 1): 144-150.[citado 2023 fev. 08 ] Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2016.05.023
Vancouver
Silva PRS, Jannes CE, Marsiglia JDC, Krieger JE, Santos RD, Pereira AC. Predictors of cardiovascular events after one year of molecular screening for Familial hypercholesterolemia [Internet]. Atherosclerosis. 2016 ; 248( 1): 144-150.[citado 2023 fev. 08 ] Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2016.05.023
Artigo de periodico
Effects of phytosterols on markers of inflammation: A systematic review and meta-analysis (2016)
Rocha, Viviane Z.; Ras, Rouyanne T.; Gagliardi, Ana C.; Mangili, Leonardo C.; Trautwein, Elke A.; Santos, Raul D.
Source: Atherosclerosis. Unidade: FM
Subjects: COLESTEROL, INFLAMAÇÃO, REVISÃO SISTEMÁTICA, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Viviane Z. et al. Effects of phytosterols on markers of inflammation: A systematic review and meta-analysis. Atherosclerosis, v. 248, n. 1, p. 76-83, 2016Tradução . . Disponível em: http://dx.doi.org/10.1016/j.atherosclerosis.2016.01.035. Acesso em: 08 fev. 2023.
APA
Rocha, V. Z., Ras, R. T., Gagliardi, A. C., Mangili, L. C., Trautwein, E. A., & Santos, R. D. (2016). Effects of phytosterols on markers of inflammation: A systematic review and meta-analysis. Atherosclerosis, 248( 1), 76-83. doi:10.1016/j.atherosclerosis.2016.01.035
NLM
Rocha VZ, Ras RT, Gagliardi AC, Mangili LC, Trautwein EA, Santos RD. Effects of phytosterols on markers of inflammation: A systematic review and meta-analysis [Internet]. Atherosclerosis. 2016 ; 248( 1): 76-83.[citado 2023 fev. 08 ] Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2016.01.035
Vancouver
Rocha VZ, Ras RT, Gagliardi AC, Mangili LC, Trautwein EA, Santos RD. Effects of phytosterols on markers of inflammation: A systematic review and meta-analysis [Internet]. Atherosclerosis. 2016 ; 248( 1): 76-83.[citado 2023 fev. 08 ] Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2016.01.035
Artigo de periodico
Homozygous familial hypercholesterolemia: phenotype rules! (2016)
Santos, Raul D.
Source: Atherosclerosis. Unidade: FM
Subjects: COLESTEROL, GENÓTIPOS, DOENÇAS HEREDITÁRIAS, HIPERCOLESTEROLEMIA, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Raul D. Homozygous familial hypercholesterolemia: phenotype rules!. Atherosclerosis, v. 248, n. 1, p. 252-254, 2016Tradução . . Disponível em: http://dx.doi.org/10.1016/j.atherosclerosis.2016.03.009. Acesso em: 08 fev. 2023.
APA
Santos, R. D. (2016). Homozygous familial hypercholesterolemia: phenotype rules!. Atherosclerosis, 248( 1), 252-254. doi:10.1016/j.atherosclerosis.2016.03.009
NLM
Santos RD. Homozygous familial hypercholesterolemia: phenotype rules! [Internet]. Atherosclerosis. 2016 ; 248( 1): 252-254.[citado 2023 fev. 08 ] Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2016.03.009
Vancouver
Santos RD. Homozygous familial hypercholesterolemia: phenotype rules! [Internet]. Atherosclerosis. 2016 ; 248( 1): 252-254.[citado 2023 fev. 08 ] Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2016.03.009

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration